about
Importance of immunopharmacogenomics in cancer treatment: Patient selection and monitoring for immune checkpoint antibodiesTechnological considerations for genome-guided diagnosis and management of cancerHigh-content molecular profiling of T-cell therapy in oncologyVDJML: a file format with tools for capturing the results of inferring immune receptor rearrangementsSuccessive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells.Harnessing shared antigens and T-cell receptors in cancer: Opportunities and challengesCharacterization of the B Cell Receptor Repertoire in the Intestinal Mucosa and of Tumor-Infiltrating Lymphocytes in Colorectal Adenoma and Carcinoma.Neutrophils dominate the immune cell composition in non-small cell lung cancerEmerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker.High-throughput T cell receptor sequencing reveals distinct repertoires between tumor and adjacent non-tumor tissues in HBV-associated HCC.T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire.The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy.Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response.Sex bias in MHC I-associated shaping of the adaptive immune system.Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial.Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapy.Somatic T-cell Receptor Diversity in a Chronic Kidney Disease PatientPopulation Linked to Electronic Health Records.TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report.T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic responseHuman T cell receptor occurrence patterns encode immune history, genetic background, and receptor specificity
P2860
Q26775034-C7588231-4224-475B-AAD7-6EF3185A5021Q28066706-151D4A5A-7246-4C7A-9CAC-F0A6309B9D34Q28066792-41613F2B-E858-404C-A458-6DC43DCCCFFFQ28843105-2C44FC6F-40BC-4B8F-9ECA-E51B0AC1128AQ33792922-8C708B0A-D244-4FF8-9A0D-A36D50D76B67Q37126636-775E3B52-DE10-42F7-A900-E8A36107ED69Q38710188-C364149D-C55A-4C86-A54D-4056926F0E8AQ38763346-24FB0E0B-7F5F-4B34-AB51-2C34B6EEBC60Q38796338-70910373-E745-410F-92F4-09BEB80CE44BQ39124682-9FD9139F-7C68-43D5-92C0-7B853BBC8949Q40448711-CE76BA64-B0A5-4E6A-B59D-F694B5415EA1Q47155794-EC13DDDF-0089-49AC-A18D-DAA26D88F8E9Q47417938-42F8F97F-E687-4967-9E72-8F77C70E8FE0Q47660305-5BE8DE75-B866-4B22-9048-EDCC78C87D4FQ50026558-63DDF278-C0DD-4EBC-8D2A-FB19C3A1E84FQ50647447-0246B545-C7E3-4764-924A-AC4C2A2BA22EQ52731759-DB9F6750-0214-4552-9F7C-F78088E89EA6Q54116803-158E9752-7B7A-45BA-B4E2-3762A6A3F33EQ55025416-C25AF9C0-CA1A-41AA-82F6-3AD65EA41FD5Q55097685-1113C769-86DA-435B-8925-93ABBA28B518Q55130948-5C255955-1E96-4ABA-B36C-B23DF0C43B21Q58129612-AF28E8C5-EC07-4B30-99C1-EE1CF67FE317Q58697400-F3055809-28B0-4A14-9B05-C96B0C71F3CD
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
T-cell receptor profiling in cancer.
@en
type
label
T-cell receptor profiling in cancer.
@en
prefLabel
T-cell receptor profiling in cancer.
@en
P2093
P2860
P1433
P1476
T-cell receptor profiling in cancer.
@en
P2093
Harlan Robins
Ilan Kirsch
Marissa Vignali
P2860
P304
P356
10.1016/J.MOLONC.2015.09.003
P577
2015-09-15T00:00:00Z